Initial Combination With Pioglitazone Study (0431-064)

Clinical trial NCT00397631 · COMPLETED

Trial details

NCT number: NCT00397631
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2006-12-19
Primary completion: 2008-06-28
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.